LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Legal & Regulatory and Reimbursement/Spine Surgeon Wins $112 Million in Royalty Battle With Medtronic
Legal & Regulatory and Reimbursement

Spine Surgeon Wins $112 Million in Royalty Battle With Medtronic

December 6, 2018 1 min read Premium comments

Advertisement

Spine Surgeon Wins $112 Million in Royalty Battle With Medtronic
Rick Sasso, M.D. / Courtesy of Indiana Spine Group
#medtronicSecondary#screwimplant#spinalimplant

An Indiana spine surgeon and inventor has prevailed in a five-year legal battle against medical device company Medtronic, with a jury awarding him $112 million in damages.

Rick Sasso, M.D., is a founding member and president of Indiana Spine Group and a board-certified orthopedic surgeon and a professor and chief of spine surgery at Indiana University School of Medicine, Department of Orthopaedic Surgery.

Sasso claimed that Medtronic violated contracts by not paying royalties on a pair of Sasso’s patented inventions: a spinal-implant system and a screw-implant system. Sasso sold the patents to Medtronic, but alleged that the company stopping paying him royalties, breaching its obligations and acting in bad faith.

According to Sasso’s complaint, his agreement with Medtronic provided for him to receive 2% of net sales on his inventions for a period of eight years. However, if a device was covered by a valid claim of a U.S. patent, then the royalty payments would continue for the life of the patent.

Sasso was the inventor of Medtronic’s Vertex system, which Sasso alleges is still covered by valid claims of numerous patents. Vertex has an estimated $200 million of sales in the United States.

Sasso also claims that Medtronic undercounted sales, not paying him royalties on numerous products that used Vertex components.

Following a month-long trial, a six-person jury returned a unanimous verdict in favor of Sasso. The jury awarded the spine surgeon $112,452,269, which is exactly the amount that Sasso requested.

Sasso’s attorney, Frederick Emhardt of Plews Shadley Racher & Braun, was pleased with the jury’s verdict. He wrote, “After a month of evidence, they learned much about spine surgery and the business of medical device sales and the need to honor contractual commitments, even if they were made by persons no longer with a company…. In a period of six hours, they unanimously rendered a verdict awarding to a dollar what Dr. Sasso requested—$112,452,269. The jury system is a bedrock of our way of life. It worked exactly the way intended by our founders.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy